SANTA ANA, Calif., June 6 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) (NYSE: EYE - News), today announced that it intends to offer, subject to market conditions and other factors, approximately $450 million aggregate principal amount of convertible senior subordinated notes due 2026, plus up to an additional $50 million of notes subject to the initial purchasers' option. The offering will be made only to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933. The notes will be unsecured senior subordinated obligations of AMO. The interest rate, conversion price and other terms of the notes will be determined by negotiations between AMO and the initial purchasers of the notes.
